231 related articles for article (PubMed ID: 31563066)
1. Dual-color magnetic-quantum dot nanobeads as versatile fluorescent probes in test strip for simultaneous point-of-care detection of free and complexed prostate-specific antigen.
Rong Z; Bai Z; Li J; Tang H; Shen T; Wang Q; Wang C; Xiao R; Wang S
Biosens Bioelectron; 2019 Dec; 145():111719. PubMed ID: 31563066
[TBL] [Abstract][Full Text] [Related]
2. Dual-color quantum dots nanobeads based suspension microarray for simultaneous detection of dual prostate specific antigens.
Min X; Huang S; Yuan C
Anal Chim Acta; 2022 Apr; 1204():339704. PubMed ID: 35397909
[TBL] [Abstract][Full Text] [Related]
3. Free and complexed prostate specific antigen in the differentiation of benign prostatic hyperplasia and prostate cancer: studies in serum and plasma samples.
España F; Royo M; Martínez M; Enguídanos MJ; Vera CD; Estellés A; Aznar J; Jiménez-Cruz JF; Heeb MJ
J Urol; 1998 Dec; 160(6 Pt 1):2081-8. PubMed ID: 9817329
[TBL] [Abstract][Full Text] [Related]
4. One-step immunostrip test for the simultaneous detection of free and total prostate specific antigen in serum.
Fernández-Sánchez C; McNeil CJ; Rawson K; Nilsson O; Leung HY; Gnanapragasam V
J Immunol Methods; 2005 Dec; 307(1-2):1-12. PubMed ID: 16277989
[TBL] [Abstract][Full Text] [Related]
5. The simultaneous detection of free and total prostate antigen in serum samples with high sensitivity and specificity by using the dual-channel surface plasmon resonance.
Jiang Z; Qin Y; Peng Z; Chen S; Chen S; Deng C; Xiang J
Biosens Bioelectron; 2014 Dec; 62():268-73. PubMed ID: 25016334
[TBL] [Abstract][Full Text] [Related]
6. In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL.
Kwiatkowski MK; Recker F; Piironen T; Pettersson K; Otto T; Wernli M; Tscholl R
Urology; 1998 Sep; 52(3):360-5. PubMed ID: 9730444
[TBL] [Abstract][Full Text] [Related]
7. SERS-Temperature Dual-Mode T-type Lateral Flow Strip for Accurate Detection of Free and Total Prostate-Specific Antigens in Blood.
Fang C; Li J; Lin B; Wang Y; Yao Y; Chen L; Zeng Y; Li L; Guo L
Anal Chem; 2024 Jan; 96(2):721-729. PubMed ID: 38176009
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous Detection of Dual Prostate Specific Antigens Using Surface-Enhanced Raman Scattering-Based Immunoassay for Accurate Diagnosis of Prostate Cancer.
Cheng Z; Choi N; Wang R; Lee S; Moon KC; Yoon SY; Chen L; Choo J
ACS Nano; 2017 May; 11(5):4926-4933. PubMed ID: 28441008
[TBL] [Abstract][Full Text] [Related]
9. Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum.
Mitrunen K; Pettersson K; Piironen T; Björk T; Lilja H; Lövgren T
Clin Chem; 1995 Aug; 41(8 Pt 1):1115-20. PubMed ID: 7543033
[TBL] [Abstract][Full Text] [Related]
10. Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen.
Luderer AA; Chen YT; Soriano TF; Kramp WJ; Carlson G; Cuny C; Sharp T; Smith W; Petteway J; Brawer MK
Urology; 1995 Aug; 46(2):187-94. PubMed ID: 7542820
[TBL] [Abstract][Full Text] [Related]
11. Ratio of free or complexed prostate-specific antigen (PSA) to total PSA: which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer?
Jung K; Elgeti U; Lein M; Brux B; Sinha P; Rudolph B; Hauptmann S; Schnorr D; Loening SA
Clin Chem; 2000 Jan; 46(1):55-62. PubMed ID: 10620572
[TBL] [Abstract][Full Text] [Related]
12. The significance of the free-to-complexed prostate-specific antigen (PSA) ratio in prostate cancer detection in patients with a PSA level of 4.1-10.0 ng/mL.
Okegawa T; Kinjo M; Watanabe K; Noda H; Kato M; Miyata A; Murata A; Yoshii M; Nutahara K; Higashihara E
BJU Int; 2000 Apr; 85(6):708-14. PubMed ID: 10759671
[TBL] [Abstract][Full Text] [Related]
13. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R
Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461
[TBL] [Abstract][Full Text] [Related]
14. Colorimetric and Fluorescent Dual-Mode Immunoassay Based on Plasmon-Enhanced Fluorescence of Polymer Dots for Detection of PSA in Whole Blood.
You PY; Li FC; Liu MH; Chan YH
ACS Appl Mater Interfaces; 2019 Mar; 11(10):9841-9849. PubMed ID: 30784256
[TBL] [Abstract][Full Text] [Related]
15. Free to complexed PSA ratio in differentiating benign prostate hyperplasia from prostate cancer.
Filella X; Alcover J; Corral JM; Molina R; Beardo P; Ballesta AM
Anticancer Res; 2001; 21(5):3717-20. PubMed ID: 11848550
[TBL] [Abstract][Full Text] [Related]
16. Measurement of circulating forms of prostate-specific antigen in whole blood immediately after venipuncture: implications for point-of-care testing.
Piironen T; Nurmi M; Irjala K; Heinonen O; Lilja H; Lövgren T; Pettersson K
Clin Chem; 2001 Apr; 47(4):703-11. PubMed ID: 11274021
[TBL] [Abstract][Full Text] [Related]
17. The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA.
Magklara A; Scorilas A; Catalona WJ; Diamandis EP
Clin Chem; 1999 Nov; 45(11):1960-6. PubMed ID: 10545066
[TBL] [Abstract][Full Text] [Related]
18. Determination of prostate-specific antigen complexed to alpha(2)-macroglobulin in serum increases the specificity of free to total PSA for prostate cancer.
Zhang WM; Finne P; Leinonen J; Salo J; Stenman UH
Urology; 2000 Aug; 56(2):267-72. PubMed ID: 10925092
[TBL] [Abstract][Full Text] [Related]
19. Analytical performance and clinical validity of two free prostate-specific antigen assays compared.
Jung K; Stephan C; Lein M; Henke W; Schnorr D; Brux B; Schürenkämper P; Loening SA
Clin Chem; 1996 Jul; 42(7):1026-33. PubMed ID: 8674185
[TBL] [Abstract][Full Text] [Related]
20. A portable chemiluminescence imaging immunoassay for simultaneous detection of different isoforms of prostate specific antigen in serum.
Liu A; Zhao F; Zhao Y; Shangguan L; Liu S
Biosens Bioelectron; 2016 Jul; 81():97-102. PubMed ID: 26922048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
